CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Hepatocellular Carcinoma|Non-small Cell Lung Cancer|Pancreatic Carcinoma|Triple-Negative Invasive Breast Carcinoma|Malignant Glioma of Brain|Colorectal Carcinoma|Gastric Carcinoma
Interventions: BIOLOGICAL: anti-MUC1 CAR-pNK cells
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Collaborators: The First People's Hospital of Hefei|Hefei Binhu Hospital